Species Distribution and Antimicrobial Susceptibility of Diverse Strains Within Burkholderia cepacia Complex
Authors:
- 30 April 2025
- journal article
- Published by SAGE Publications in Microbial Drug Resistance
- Vol. 31 (5) , 154-161
Abstract
Purpose: The aim of the present study was to examine the clinical distribution and antibiotic susceptibility of the Burkholderia cepacia complex (BCC). Methods: The BCC clinical strains were obtained from the First Affiliated Hospital of Zhejiang University School of Medicine in China from January 2019 to January 2024, and hisA gene sequencing was employed for strain identification. The in vitro susceptibility of various antibacterials was measured through the disk diffusion method and the broth microdilution method. Results: A total of 386 strains of BCC were collected. Among them, the most common strains were B. cenocepacia (45.9%), B. multivorans (45.1%), and B. contaminans (7.0%). B. multivorans was the main one in respiratory specimens, whereas B. cenocepacia dominated in blood specimens. B. cenocepacia , B. multivorans , and B. contaminans exhibited a susceptibility over 95% to meropenem and sulfamethoxazole–trimethoprim, whereas varying sensitivities were displayed to levofloxacin, ceftazidime, and minocycline ( p < 0.05). Among tetracyclines, eravacycline exhibited the lowest minimum inhibitory concentration 90 (MIC90) values 1 µg/mL for B. cenocepacia , 1 µg/mL for B. multivorans , and 2 µg/mL for B. contaminans . This was followed by tigecycline (MIC90: 2 µg/mL, 2 µg/mL, and 4 µg/mL, respectively), minocycline (MIC90: 8 µg/mL, 2 µg/mL, and 8 µg/mL, respectively), and omadacycline (MIC90: 8 µg/mL, 4 µg/mL, and 16 µg/mL, respectively). Compared with the broth microdilution method, the category agreement (CA) of sulfamethoxazole–trimethoprim and ceftazidime was >95%, and the very major error was in vitro antimicrobial susceptibility of different BCC strains, with eravacycline demonstrating lower MIC values compared with tigecycline, minocycline, and omadacycline.Keywords
This publication has 27 references indexed in Scilit:
- Burkholderia cepacia complex in cystic fibrosis: critical gaps in diagnosis and therapyAnnals of Medicine, 2024
- Two consecutive outbreaks caused by chlorhexidine mouthwash contaminated with Burkholderia contaminans in a two-hospital tertiary care systemJournal of Hospital Infection, 2023
- Cepacia syndrome in cystic fibrosis: A systematic review of the literature and possible new perspectives in treatmentPediatric Pulmonology, 2023
- An outbreak of Burkholderia contaminans at a quaternary children’s hospital linked to equipment reprocessingInfection Control & Hospital Epidemiology, 2022
- Activity of Omadacycline and Other Tetracyclines Against Contemporary Gram-Negative Pathogens from New York City HospitalsMicrobial Drug Resistance, 2020
- Whole Genome Sequence Analysis of Burkholderia contaminans FFH2055 Strain Reveals the Presence of Putative β-LactamasesCurrent Microbiology, 2019
- Antibiotic resistance in Burkholderia speciesDrug Resistance Updates, 2016
- Increase in isolation of Burkholderia contaminans from Spanish patients with cystic fibrosisClinical Microbiology and Infection, 2015
- Identification of species of the Burkholderia cepacia complex by sequence analysis of the hisA geneJournal of Medical Microbiology, 2010
- Approaches to measure the fitness of Burkholderia cepacia complex isolatesJournal of Medical Microbiology, 2010